AT-001

AT-001 is an investigational, novel Aldose Reductase Inhibitor (ARI) being developed as an oral therapy for the treatment of Diabetic Cardiomyopathy (DbCM).


Cat. No.: EX-A4257	Purity: >98%

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
50mg	600	In-stock
100mg	785	In-stock
200mg	1285	In-stock
500mg	1985	In-stock
1g	3000	In-stock
5g	Get quote

Send PO to E-mail:order@excenen.com; or Fax:+86 020 81619670

Discount Request


Synonyms	Aldose reductase-IN-1
CAS No.	1355612-71-3
Purity	>98%
Formula	C17H10F3N5O3S
Mol Weight	421.353
Appearance	solid powder
Solubility	Soluble in DMSO
Shelf Life	>2 years if stored properly
Storage	Powder -20℃ 2 years; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. ALDOSE REDUCTASE INHIBITORS AND USES THEREOF (https://www.google.com/patents/WO2014113380A1)
CoA	CoA of AT-001

Smiles:	O=C1C2=NC=CN=C2C(CC(O)=O)=NN1CC3=NC4=C(C=CC(C(F)(F)F)=C4)S3


		Search